Cargando…
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
OBJECTIVE: Follistatin-like protein 1 (FSTL1) is widely recognised as a secreted glycoprotein, but its role in modulating macrophage-related inflammation during liver fibrosis has not been documented. Herein, we aimed to characterise the roles of macrophage FSTL1 in the development of liver fibrosis...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664121/ https://www.ncbi.nlm.nih.gov/pubmed/35140065 http://dx.doi.org/10.1136/gutjnl-2021-325150 |
_version_ | 1784831034182860800 |
---|---|
author | Rao, Jianhua Wang, Hao Ni, Ming Wang, Zeng Wang, Ziyi Wei, Song Liu, Mu Wang, Peng Qiu, Jiannan Zhang, Lei Wu, Chen Shen, Hongbing Wang, Xuehao Cheng, Feng Lu, Ling |
author_facet | Rao, Jianhua Wang, Hao Ni, Ming Wang, Zeng Wang, Ziyi Wei, Song Liu, Mu Wang, Peng Qiu, Jiannan Zhang, Lei Wu, Chen Shen, Hongbing Wang, Xuehao Cheng, Feng Lu, Ling |
author_sort | Rao, Jianhua |
collection | PubMed |
description | OBJECTIVE: Follistatin-like protein 1 (FSTL1) is widely recognised as a secreted glycoprotein, but its role in modulating macrophage-related inflammation during liver fibrosis has not been documented. Herein, we aimed to characterise the roles of macrophage FSTL1 in the development of liver fibrosis. DESIGN: Expression analysis was conducted with human liver samples obtained from 33 patients with liver fibrosis and 18 individuals without fibrosis serving as controls. Myeloid-specific FSTL1-knockout (FSTL1(M-KO)) mice were constructed to explore the function and mechanism of macrophage FSTL1 in 3 murine models of liver fibrosis induced by carbon tetrachloride injection, bile duct ligation or a methionine-deficient and choline-deficient diet. RESULTS: FSTL1 expression was significantly elevated in macrophages from fibrotic livers of both humans and mice. Myeloid-specific FSTL1 deficiency effectively attenuated the progression of liver fibrosis. In FSTL1(M-KO) mice, the microenvironment that developed during liver fibrosis showed relatively less inflammation, as demonstrated by attenuated infiltration of monocytes/macrophages and neutrophils and decreased expression of proinflammatory factors. FSTL1(M-KO) macrophages exhibited suppressed proinflammatory M1 polarisation and nuclear factor kappa B pathway activation in vivo and in vitro. Furthermore, this study showed that, through its FK domain, FSTL1 bound directly to the pyruvate kinase M2 (PKM2). Interestingly, FSTL1 promoted PKM2 phosphorylation and nuclear translocation, reduced PKM2 ubiquitination to enhance PKM2-dependent glycolysis and increased M1 polarisation. Pharmacological activation of PKM2 (DASA-58) partially countered FSTL1-mediated glycolysis and inflammation. CONCLUSION: Macrophage FSTL1 promotes the progression of liver fibrosis by inducing M1 polarisation and inflammation based on the intracellular PKM2 reprogramming function of macrophages. |
format | Online Article Text |
id | pubmed-9664121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96641212022-11-15 FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 Rao, Jianhua Wang, Hao Ni, Ming Wang, Zeng Wang, Ziyi Wei, Song Liu, Mu Wang, Peng Qiu, Jiannan Zhang, Lei Wu, Chen Shen, Hongbing Wang, Xuehao Cheng, Feng Lu, Ling Gut Hepatology OBJECTIVE: Follistatin-like protein 1 (FSTL1) is widely recognised as a secreted glycoprotein, but its role in modulating macrophage-related inflammation during liver fibrosis has not been documented. Herein, we aimed to characterise the roles of macrophage FSTL1 in the development of liver fibrosis. DESIGN: Expression analysis was conducted with human liver samples obtained from 33 patients with liver fibrosis and 18 individuals without fibrosis serving as controls. Myeloid-specific FSTL1-knockout (FSTL1(M-KO)) mice were constructed to explore the function and mechanism of macrophage FSTL1 in 3 murine models of liver fibrosis induced by carbon tetrachloride injection, bile duct ligation or a methionine-deficient and choline-deficient diet. RESULTS: FSTL1 expression was significantly elevated in macrophages from fibrotic livers of both humans and mice. Myeloid-specific FSTL1 deficiency effectively attenuated the progression of liver fibrosis. In FSTL1(M-KO) mice, the microenvironment that developed during liver fibrosis showed relatively less inflammation, as demonstrated by attenuated infiltration of monocytes/macrophages and neutrophils and decreased expression of proinflammatory factors. FSTL1(M-KO) macrophages exhibited suppressed proinflammatory M1 polarisation and nuclear factor kappa B pathway activation in vivo and in vitro. Furthermore, this study showed that, through its FK domain, FSTL1 bound directly to the pyruvate kinase M2 (PKM2). Interestingly, FSTL1 promoted PKM2 phosphorylation and nuclear translocation, reduced PKM2 ubiquitination to enhance PKM2-dependent glycolysis and increased M1 polarisation. Pharmacological activation of PKM2 (DASA-58) partially countered FSTL1-mediated glycolysis and inflammation. CONCLUSION: Macrophage FSTL1 promotes the progression of liver fibrosis by inducing M1 polarisation and inflammation based on the intracellular PKM2 reprogramming function of macrophages. BMJ Publishing Group 2022-12 2022-02-09 /pmc/articles/PMC9664121/ /pubmed/35140065 http://dx.doi.org/10.1136/gutjnl-2021-325150 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Hepatology Rao, Jianhua Wang, Hao Ni, Ming Wang, Zeng Wang, Ziyi Wei, Song Liu, Mu Wang, Peng Qiu, Jiannan Zhang, Lei Wu, Chen Shen, Hongbing Wang, Xuehao Cheng, Feng Lu, Ling FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 |
title | FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 |
title_full | FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 |
title_fullStr | FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 |
title_full_unstemmed | FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 |
title_short | FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 |
title_sort | fstl1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of pkm2 |
topic | Hepatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664121/ https://www.ncbi.nlm.nih.gov/pubmed/35140065 http://dx.doi.org/10.1136/gutjnl-2021-325150 |
work_keys_str_mv | AT raojianhua fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT wanghao fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT niming fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT wangzeng fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT wangziyi fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT weisong fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT liumu fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT wangpeng fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT qiujiannan fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT zhanglei fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT wuchen fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT shenhongbing fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT wangxuehao fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT chengfeng fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 AT luling fstl1promotesliverfibrosisbyreprogrammingmacrophagefunctionthroughmodulatingtheintracellularfunctionofpkm2 |